Aim: To investigate the influence of reproductive medicine in maternal death cases in Japan. Methods: This retrospective study investigated the incidence of maternal deaths related to reproductive medicine in Japan from 2013 to 2015, and the relationship between fertility treatment and maternal death.
Introduction
Recently, the outcomes of fertility treatment have improved with the progress in assisted reproduction technology. Therefore, women with severe diseases can experience pregnancy with close supervision and require a supportive environment. During this study, an in-depth analysis of the relationship between reproductive medicine and maternal deaths reported in Japan in 2013-2015 was performed.
Methods
The Japanese Society of Obstetrics and Gynecology (JSOG) created Database Registered Enterprise of JSOG as a new registration system in 1986, and the Committee on Registration of Reproductive medicine of the JSOG analyzes and records data for each year. [1] [2] [3] Much of these data are outcomes of reproductive medicine and in vitro fertilization. However, maternal outcomes are not reported with these data.
Information regarding all maternal deaths in Japan has been gathered by the Japan Association of Obstetricians and Gynecologists (JAOG) since 2010. When maternal death occurs in Japan, a detailed report is submitted to the JAOG, and the individual data are analyzed by the Maternal Death Exploratory Committee (T. I, is the Chairman of the Committee). [1] [2] [3] This committee consists of 15 obstetricians, four anesthesiologists, two pathologists, one emergency physician and various specialists who attend the review sessions each month to make annual recommendations to reduce the maternal mortality rate. [1] [2] [3] The present study was performed by this committee as part of a series of analyses of maternal deaths in Japan. Maternal mortality data for the period from 2012 to 2015 were extracted from this database. All data used for this study were reviewed by the Maternal Death Exploratory Committee.
Data regarding maternal background, age, parity, methods of fertility treatment, cause of maternal death and the relationship between fertility treatment and maternal death were collected. This study was approved by the ethics committee of the National Cerebral and Cardiovascular Center of Japan under the title 'Research on a model project regarding surveys and evaluations on maternal mortality in Japan' (receipt number N18-34).
Results
The combined number of all live births and fetal deaths in Japan was 3 111 981 during 2013-2015 in Japan. The total number of maternal deaths from January 2013 to December 2015 in Japan was 134. Fifteen (11.2%) women who died during this period had undergone fertility treatment. Data for these women were retrospectively analyzed ( Table 1) .
The median age was 36 years (31-45 years). Eleven (73.3%) women were older than 35 years. There were 13 nulliparous women (86.7%) and two multiparous women (13.3%). Fertility treatment methods were as follows: in vitro fertilization and embryo transfer, six (40.0%) cases; frozen embryo transfer, four (26.6%) cases; artificial insemination by husband, one (6.6%) case; blastocyst transfer, one (6.6%) case; clomiphene administered to stimulate ovulation, one (6.6%) case; and unknown, two (13.3%) cases.
Each maternal death case related to atonic bleeding and peripartum cardiomyopathy involved a twin pregnancy. It is possible that fertility treatment was the cause of the twin pregnancy, and twin pregnancy is a risk factor of atonic bleeding and peripartum cardiomyopathy.
Pregnancy with severe maternal complications occurred in four (40.0%) women who died. These complications were active systemic lupus erythematosus, exacerbated depression, uncontrolled arrhythmia and uncontrolled type 2 diabetes mellitus. At least three of these four women died due to these complications. One (6.6%) woman decreased her dose of antihypertensive drugs because of pregnancy and experienced an intracerebral hemorrhage during pregnancy.
Discussion
The present study resulted in two important new findings. First, 10% of maternal deaths in Japan involved pregnancies that were a result of fertility treatment. The rate of fertility treatment among women and maternal death is similar to the birth rate due to assisted reproductive technology in Japan. Second, 30% of maternal death cases involving fertility treatment also involved severe uncontrolled complications due to diseases for which pregnancy is discouraged.
There have been several reports of reproductive medicine and maternal death. [4] [5] [6] However, there are no reports that mention the relationship between reproductive medicine and maternal death. This investigation is few reports to link reproductive medicine and maternal death.
In Japan, 10% of couples experience infertility. One out of every 30 women in Japan becomes pregnant with assisted reproductive technology. We suggest that pregnancies following fertility treatment may be associated with no more risk than natural pregnancies. Although we do not dismiss the wishes of women who want children, those with severe complications should undergo thorough preconception counseling. Fertility treatment should be initiated after planning pregnancy management. In this study, it was unclear whether women who undergo fertility treatment would experience more severe medical complications than those who conceived naturally. Fertility treatment increased pregnancies with obstetrics complications such as twin pregnancy, hypertension disorder of pregnancy, placenta previa, gestational diabetes mellitus, placental abruption, antepartum hemorrhage, postpartum hemorrhage and cesarean sections. 7, 8 The underlying mechanisms involved in the association between reproductive medicine and poor outcomes in the pregnancies are uncertain. 7 However, in this study, it was unclear whether the two maternal deaths involving twin pregnancies were a result of reproductive medicine. We suggest that detection and treatment of severe uncontrolled complications before starting fertility treatment should be performed to avoid maternal death.
The rate of successful pregnancies for women with infertility has improved due to advances in technology, but some of these women have experienced severe complications. Therefore, we suggest that women with severe complications should undergo fertility treatment only after receiving comprehensive counseling from specialists, and that the medical history of all women undergoing fertility treatment should be reviewed before treatment. Although it is predicted that pregnancies due to assisted reproductive technology will increase in the future, all patients should be fully informed of the risks.
